Malignant melanoma: treatments emerging, but early detection is still key

Cleve Clin J Med. 2002 Jul;69(7):529, 533-4, 536-8 passim. doi: 10.3949/ccjm.69.7.529.

Abstract

Although we are beginning to develop treatment options for malignant melanoma, earlier recognition of potential primary melanomas remains the most effective way to increase survival in this highly malignant disease. This article reviews prominent risk factors for melanoma, key physical findings in at-risk patients, new melanoma staging guidelines, and recent and emerging therapy options.

Publication types

  • Review

MeSH terms

  • Adult
  • Dysplastic Nevus Syndrome / diagnosis
  • Female
  • Heliotherapy / adverse effects
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Male
  • Melanoma / diagnosis*
  • Melanoma / etiology
  • Melanoma / pathology
  • Melanoma / secondary
  • Melanoma / therapy*
  • Middle Aged
  • Neoplasm Staging
  • Precancerous Conditions / diagnosis
  • Recombinant Proteins
  • Risk Factors
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / etiology
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Ultraviolet Rays / adverse effects

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins